Antiepileptic Drugs Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Antiepileptic Drugs Market
Antiepileptic Drugs Market: By Type (First Generation Drugs, Second Generation Drugs and Pipeline Drugs); By Geography (Global, Americas, Europe, APAC and ROW) - Study With Forecast (2018-2023)
Report Code : HCR 0142
Updated Date: 29 October, 2018  

1. Antiepileptic Drugs Market - Overview
1.1. Definitions and Scope
2. Antiepileptic Drugs Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Antiepileptic Drugs Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Antiepileptic Drugs Market – Startup companies Scenario
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. Antiepileptic Drugs Market – Industry Market Entry Scenario
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. Antiepileptic Drugs Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. Antiepileptic Drugs Market -Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
7.4. Suppliers and distributors Market Share
8. Antiepileptic Drugs Market – By Type (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Application Revenue and Trend Research
8.3. Product Segment Analysis
8.3.1. First Generation Drugs Valproate (Depakote) Oxycarbazepine ((Trileptal) Carbamazepine (Carbatrol) Phenobarbital (Luminal) Primidone (Mysoline) Ethosuximide (Zarontin) Topiramate (Topamax)
8.3.2. Second Generation Drugs Pregabalin (Lyrica) Lamotrigine (Lamictal) Eslicarbazepine acetate Zonisamide (Zonegran) Lacosamide (Vimpat) Levetiracetam (Keppra) (Aptiom/Zebinix) Rufinamide (Banzel/Inovelon) Perampanel (Fycompa) Ezogabine/retigabine (Trobalt/Potiga)
8.3.3. Pipeline Drugs Buspirone Everoline UCB0942 (PPSI) GWP42006 Lacosamide TAK-932 Brivaracetam (UCB Pharma Ltd) Ganaxolone (Marinus Pharmaceuticals) USL261 (Upsher Smith Laboratories, Inc.) Perampanel (Eisai Co) YKP3089 (SK Life Sciences)
8.3.4. Others
9. Antiepileptic Drugs - By Geography (Market Size -$Million / $Billion)
9.1. Antiepileptic Drugs Market - North America Segment Research
9.2. North America Market Research (Million / $Billion)
9.2.1. Segment type Size and Market Size Analysis 
9.2.2. Revenue and Trends
9.2.3. Application Revenue and Trends by type of Application
9.2.4. Company Revenue and Product Analysis
9.2.5. North America Product type and Application Market Size U.S. Canada Mexico Rest of North America
9.3. Antiepileptic Drugs - South America Segment Research
9.4. South America Market Research (Market Size -$Million / $Billion)
9.4.1. Segment type Size and Market Size Analysis 
9.4.2. Revenue and Trends
9.4.3. Application Revenue and Trends by type of Application
9.4.4. Company Revenue and Product Analysis
9.4.5. South America Product type and Application Market Size Brazil Venezuela Argentina Ecuador Peru Colombia Costa Rica Rest of South America
9.5. Antiepileptic Drugs - Europe Segment Research
9.6. Europe Market Research (Market Size -$Million / $Billion)
9.6.1. Segment type Size and Market Size Analysis 
9.6.2. Revenue and Trends
9.6.3. Application Revenue and Trends by type of Application
9.6.4. Company Revenue and Product Analysis
9.6.5. Europe Segment Product type and Application Market Size U.K Germany Italy France Netherlands Belgium Spain Denmark Rest of Europe
9.7. Antiepileptic Drugs – APAC Segment Research
9.8. APAC Market Research (Market Size -$Million / $Billion)
9.8.1. Segment type Size and Market Size Analysis 
9.8.2. Revenue and Trends
9.8.3. Application Revenue and Trends by type of Application
9.8.4. Company Revenue and Product Analysis
9.8.5. APAC Segment – Product type and Application Market Size China Australia Japan South Korea India Taiwan Malaysia
10. Antiepileptic Drugs Market - Entropy
10.1. New product launches
10.2. M&A's, collaborations, JVs and partnerships
11. Antiepileptic Drugs Market – Industry / Segment Competition landscape
11.1. Market Share Analysis
11.1.1. Market Share by Country- Top companies
11.1.2. Market Share by Region- Top 10 companies
11.1.3. Market Share by type of Application – Top 10 companies
11.1.4. Market Share by type of Product / Product category- Top 10 companies
11.1.5. Market Share at global level- Top 10 companies
11.1.6. Best Practises for companies
12. Antiepileptic Drugs Market – Key Company List by Country
13. Antiepileptic Drugs Market Company Analysis
13.1. Market Share, Company Revenue, Products, M&A, Developments
13.2. Abbott Laboratories
13.3. Cephalon
13.4. GlaxoSmithKline
13.5. Johnson & Johnson
13.6. Novartis AG
13.7. Pfizer
13.8. Sanofi S.A
13.9. Sunovion Pharmaceuticals
13.10. UCB Pharma Ltd.
13.11. Valeant Pharmaceuticals International
13.12. Company 12
13.13. Company 13
13.14. Company 14 and More
"*Financials would be provided on a best efforts basis for private companies"
14. Antiepileptic Drugs Market -Appendix
14.1. Abbreviations
14.2. Sources
15. Antiepileptic Drugs Market -Methodology
15.1. Research Methodology
15.1.1. Company Expert Interviews
15.1.2. Industry Databases
15.1.3. Associations
15.1.4. Company News
15.1.5. Company Annual Reports
15.1.6. Application Trends
15.1.7. New Products and Product database
15.1.8. Company Transcripts
15.1.9. R&D Trends
15.1.10. Key Opinion Leaders Interviews
15.1.11. Supply and Demand Trends
Please select Licence
Single User Licence:
US $5250
Corporate User Licence:
US $7250
Related Reports